TM7SF2 and colorectal carcinoma: Intracellular metabolite analysis revealed decreased levels of cholesterol, triglycerides, and FFAs in CRC cells following M16 knockdown, with overexpression of TM7SF2 mitigating these effects (Fig. 7C-E).